Allen C. Ho
Expertise in
27
conditions

Dr. Allen C. Ho

Ophthalmology
840 Walnut Street, Floor 10, 
Philadelphia, PA 
Accepting New Patients
Referral may be required
Expertise in
27
conditions
840 Walnut Street, Floor 10, 
Philadelphia, PA 

Overview

Allen Ho is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania.

Dr. Ho is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Vitrectomy, and Cataract Removal.

Dr. Ho is board certified in Ophthalmology. He is actively involved in clinical research, co-authoring 228 peer reviewed articles and participating in 5 clinical trials. Dr. Ho is currently accepting new patients.

Graduate Institution

Columbia University College Of Physicians/Surgeons

Residency

Wills Eye Hosp (HOSP CLOSED 7/13/06-NOW SURGI CTR)

Specialties

Ophthalmology

Licenses

Ophthalmology in NJ

Board Certifications

Ophthalmology

Fellowships

Manhattan Eye, Ear & Throat Institute

Hospital Affiliations

Jefferson Abington Hospital
Thomas Jefferson University Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

840 Walnut Street, Floor 10, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Ho has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Retinitis Pigmentosa
Retinoblastoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase I/IIa Dose Escalation Safety and Efficacy Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium Cells Transplanted Subretinally in Patients With Advanced Dry-Form Age-Related Macular Degeneration (Geographic Atrophy)
Phase I/IIa Dose Escalation Safety and Efficacy Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium Cells Transplanted Subretinally in Patients With Advanced Dry-Form Age-Related Macular Degeneration (Geographic Atrophy)
Enrollment Status: Active_not_recruiting
Publish Date: April 27, 2026
Intervention Type: Biological
Study Drug: OpRegen
Study Phase: Phase 1/Phase 2
New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System
New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System
Enrollment Status: Terminated
Publish Date: December 23, 2021
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE III)
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE III)
Enrollment Status: Active_not_recruiting
Publish Date: February 05, 2021
Intervention Type: Device
Study Phase: Not Applicable
Inflammasomes in Cell Death in Macular Hole, Epiretinal Membrane, and Rhegmatogenous Retinal Detachment
Inflammasomes in Cell Death in Macular Hole, Epiretinal Membrane, and Rhegmatogenous Retinal Detachment
Enrollment Status: Completed
Publish Date: August 17, 2018
Intervention Type: Procedure
Comparative Analysis of Three-dimensional Heads-up Display Surgical Platform to Standard Operating Microscope for Vitreoretinal Surgery
Comparative Analysis of Three-dimensional Heads-up Display Surgical Platform to Standard Operating Microscope for Vitreoretinal Surgery
Enrollment Status: Completed
Publish Date: August 17, 2018
Intervention Type: Device
View 4 Less Clinical Trials

227 Total Publications

Readability of Retina Patient Education Materials Generated With a Large Language Model.
Readability of Retina Patient Education Materials Generated With a Large Language Model.
Journal: Journal of vitreoretinal diseases
Published: May 25, 2026
Similar Doctors
Expertise in
30
conditions
Dr. Yoshihiro Yonekawa
Ophthalmology | Pediatrics
Expertise in
30
conditions
Dr. Yoshihiro Yonekawa
Ophthalmology | Pediatrics
Referral may be required
840 Walnut Street, Floor 10, 
Philadelphia, PA 
 (12.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Yoshihiro Yonekawa is a Pediatrics specialist and an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Yonekawa is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Familial Exudative Vitreoretinopathy, Endophthalmitis, Vitrectomy, and Trabeculectomy. Dr. Yonekawa is board certified in Ophthalmology. Dr. Yonekawa is currently accepting new patients.

Expertise in
27
conditions
Dr. Tomas S. Aleman
Ophthalmology
Expertise in
27
conditions
Dr. Tomas S. Aleman
Ophthalmology
Referral may be required

Scheie Eye Institute Perelman

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
 (11.8 miles away)
215-662-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tomas Aleman is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Aleman is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Choroideremia, Leber Congenital Amaurosis, Retinopathy Pigmentary Mental Retardation, and Cone-Rod Dystrophy. Dr. Aleman is board certified in Ophthalmology, 2019. Dr. Aleman is currently accepting new patients.

Expertise in
18
conditions
Dr. Sunir J. Garg
Ophthalmology
Expertise in
18
conditions
Dr. Sunir J. Garg
Ophthalmology
Referral may be required

Ophthalmology - Wills Eye Hospital

840 Walnut Street, Floor 10, 
Philadelphia, PA 
 (12.6 miles away)
800-331-6634
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sunir Garg is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Garg is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Endophthalmitis, Retinal Detachment, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Trabeculectomy. Dr. Garg is board certified in Ophthalmology. Dr. Garg is currently accepting new patients.

Frequently Asked Questions about Dr. Allen C. Ho

Is Dr. Allen C. Ho a top-rated expert for Age-Related Macular Degeneration (ARMD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Allen C. Ho is classified as an Elite expert for Age-Related Macular Degeneration (ARMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Allen C. Ho specialize in?

While Dr. Allen C. Ho is a Ophthalmology, they have specific expertise in Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Retinal Vein Occlusion. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Allen C. Ho participate in research or clinical trials?

Yes. Dr. Allen C. Ho has published 227 articles and abstracts on conditions like Age-Related Macular Degeneration (ARMD). You can view a list of Dr. Allen C. Ho's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Allen C. Ho accept my insurance?

Dr. Allen C. Ho accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ho's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 14 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile